Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25–Driven Intestinal Inflammation

Julia Manasson, David S. Wallach, Giuliana Guggino, Matthew Stapylton, Michelle H. Badri, Gary Solomon, Soumya M. Reddy, Roxana Coras, Alexander A. Aksenov, Drew R. Jones, Parvathy V. Girija, Andrea L. Neimann, Adriana Heguy, Leopoldo N. Segal, Pieter C. Dorrestein, Richard Bonneau, Monica Guma, Francesco Ciccia, Carles Ubeda, Jose C. ClementeJose U. Scher

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25–Driven Intestinal Inflammation'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology